Low molecular weight heparin for the prevention of severe preeclampsia: where next?
SourceBritish Journal of Clinical Pharmacology, 84, 4, (2018), pp. 673-678
1 april 2018
Article / Letter to editor
Display more detailsDisplay less details
British Journal of Clinical Pharmacology
SubjectRadboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences
Low molecular weight heparin has been extensively evaluated for the prevention of preeclampsia in high-risk pregnant women; however, the results from these trials have been conflicting. This review discusses the potential mechanisms of action of low molecular weight heparin for the prevention of severe preeclampsia, how to optimize the selection of high-risk women for participation in future trials, and the importance of trial standardization.
Upload full text